Enoxaparin Metabolism in Reconstructive Surgery Patients

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

Also called NCT02411292

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Phase 2
Enrolled
  • 110 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02411292
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02411292. Allocation not applicable; no masking; primary purpose other. Start 2015-03 (actual); primary completion 2016-03 (actual). Results posted on 2017-09-13.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Enoxaparin Metabolism in Reconstructive Surgery Patients
Condition
Venous Thromboembolism
Condition
Deep Venous Thrombosis
Condition
Pulmonary Embolus
Condition
Reconstructive Surgery
Intervention (Drug)
Enoxaparin
Lead sponsor
University of Utah (class: other)

Record details

Record id
cardio:ct-nct02411292
Content hash
f508e557bd38a1be95cdb6692a145173245f33b619f4bff3498adf93fb6989f1